C-type virus-associated antigens and their relevance to human leukemia control.
This review describes oncogenic C-type virus and virus-associated antigens as phenotypic expressions of virus activities in malignant cells and cell surface antigens acquired by malignant transformation. The range of host-immune responses to these antigens in experimental systems is discussed in relation to the immunotherapy and immunoprophylaxis of human cancer patients.
D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D002462:Cell Membrane / Q000276:immunology; D003429:Cross Reactions; D000939:Epitopes; D006023:Glycoproteins / Q000276:immunology; D007116:Immunization, Passive; D007938:Leukemia / Q000276:immunology / Q000517:prevention & control*; D008214:Lymphocytes / Q000276:immunology; D010641:Phenotype; D012190:Retroviridae / Q000276:immunology*; D014611:Vaccination; D014764:Viral Proteins / Q000276:immunology
D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D000939:Epitopes; D006023:Glycoproteins; D014764:Viral Proteins